Investor Relations
9M and Q3 2024 results
Key facts
Epidemiology
Contacts
Latest aide memoire
Upcoming events
Goodbody, 17th Annual Equity Conference 2024, Dublin [IR]
Goldman Sachs, Sustainable Healthcare Forum, London [Management]
Berenberg, Pharma CFO Series, London [Management]
Annual Reports
Archive
Investor enquiries
Main Contacts
Andy Barnett
Head of Investor Relations
Morgan Sanford
Oncology
Christer Gruvris
BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
Finance & Fixed Income
Lauren Swales
Rare Disease
Isabel Gibson
Oncology
Philip Sparks
BioPharmaceuticals
(Vaccines & Immune Therapies)
Rachel Korolyshun
Rare Disease,
Environment, Social and Governance
Elizabeth Walton
BioPharmaceuticals
(Respiratory & Immunology), Environment, Social and Governance
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
